The civic record
Read. Follow. Verify.National Hepatitis Testing Day, 2024
Record date · May 17, 2024
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
President Biden issued a proclamation designating May 19, 2024, as National Hepatitis Testing Day to raise awareness about viral hepatitis. The document highlights the administration's proposed plans to increase testing, expand access to treatments, and improve vaccination rates for hepatitis B and C.
This proclamation highlights federal health priorities and proposed policy changes regarding the diagnosis and treatment of viral hepatitis in the United States.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Uninsured individuals
The proposed subscription model for hepatitis C drugs aims to expand access to medication for this group.
Medicaid enrollees
The proposed subscription model for hepatitis C drugs includes individuals enrolled in Medicaid.
Healthcare professionals
The administration's plan includes investments in training programs for healthcare professionals.
Key Facts
- May 19, 2024, is designated as National Hepatitis Testing Day.
- Hepatitis C is curable with treatment that is 95 percent effective.
- The administration proposes a subscription model to expand access to hepatitis C drugs for uninsured and specific public program enrollees.
- The CDC recommends hepatitis B vaccination for children and screening/vaccination for adults under 60.
Frequently Asked Questions
What is the purpose of National Hepatitis Testing Day?
What specific actions is the administration proposing regarding hepatitis?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Subscription Drug Model
The administration is proposing a shift toward a subscription-based payment model for hepatitis C medications to increase accessibility.
Connected Entities
Sources
www.federalregister.gov
Analysis Score
0–100- Significance45How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools
